Tan Tock Seng Hospital is a tertiary referral hospital in Singapore, located in Novena. The hospital has 45 clinical and allied health departments, 16 specialist centres and is powered by more than 8,000 healthcare staff.

There are 1,700 beds in Tan Tock Seng Hospital.

During the past decade, Tan Tock Seng Hospital conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 21 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 15 clinical trials were completed. i.e. 27.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tan Tock Seng Hospital" #1 sponsor was "Tan Tock Seng Hospital" with 43 trials, followed by "National University Hospital, Singapore" with 16 trials sponsored, "The University of Queensland" with 5 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "National Cancer Centre, Singapore" with 4 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tan Tock Seng Hospital" #1 collaborator was "Tan Tock Seng Hospital" with 28 trials as a collaborator, "Nanyang Technological University" with 10 trials as a collaborator, "National University Hospital, Singapore" with 10 trials as a collaborator, "Changi General Hospital" with 9 trials as a collaborator and "Singapore General Hospital" with 8 trials as a collaborator. Other collaborators include 173 different institutions and companies that were collaborators in the rest 132 trials.

According to Clinical.Site data, the most researched conditions in "Tan Tock Seng Hospital" are "Stroke" (9 trials), "Coronary Artery Disease" (7 trials), "Heart Failure" (5 trials), "Atherosclerosis" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Tan Tock Seng Hospital" in a lesser frequency.

Most popular intervention types in "Tan Tock Seng Hospital" are "Drug" (72 trials), "Device" (36 trials), "Other" (33 trials), "Procedure" (9 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Meropenem" (3 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "FDG ligand" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tan Tock Seng Hospital" are 154 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 65 active trials in "Tan Tock Seng Hospital". 4 are not yet recruiting, 36 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 61 completed trials in Tan Tock Seng Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Tan Tock Seng Hospital, 6 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 49 trials that are defined as “Not Applicable".

Tan Tock Seng Hospital has several departments that took part in Clinical trials: "Tan Tock Seng Hospital Rehabilitation Centre" - 7 trials, "Tan Tock Seng Hospital; Oncology" - 5 trials, "Tan Tock Seng Hospital; Ophthalmology Department" - 4 trials, "National Centre for Infectious Diseases, Tan Tock Seng Hospital" - 2 trials